Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome

Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome

Aims: In our single-center retrospective study we evaluated whether level of different checkpoint molecules in bone marrow biopsies at diagnosis affect the clinical course of patients with myelodysplastic syndrome (MDS). Methods and results: A consecutive cohort of 55 MDS patients treated in our cen...

Full description

Bibliographic Details
Main Authors: Nikolai Tcvetkov, Artem Gusak, Elena Morozova, Ivan Moiseev, Vadim Baykov, Maria Barabanshikova, Kirill Lepik, Evgenyi Bakin, Julia Vlasova, Anna Osipova, Ludmila Zubarovskaya, Boris Afanasyev
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Leukemia Research Reports
Subjects:
Myelodysplastic syndrome
Immune checkpoints
Prognosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048920300212

Internet

http://www.sciencedirect.com/science/article/pii/S2213048920300212

Similar Items